+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma



Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma



Cornea 30(4): 486; Author Reply 486-7




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056795772

Download citation: RISBibTeXText

PMID: 21107255

DOI: 10.1097/ico.0b013e3181e2cf72


Related references

Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea 24(4): 443-448, 2005

Topical 0.002% Mitomycin C for the Treatment of Conjunctival-Corneal Intraepithelial Neoplasia and Squamous Cell Carcinoma. Cornea 24(4): 443-448, 2005

Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. American Journal of Ophthalmology 142(4): 673-675, 2006

Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. American Journal of Ophthalmology 137(5): 950-951, 2004

Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C. Archives of Ophthalmology 117(4): 544-545, 1999

Topical mitomycin C for conjunctival-corneal squamous cell carcinoma. American Journal of Ophthalmology 135(1): 122-3; Author Reply 123-4, 2003

Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ophthalmic Plastic and Reconstructive Surgery 25(4): 296-299, 2009

Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Yearbook of Ophthalmology 2012: 227-228, 2012

Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. American Journal of Ophthalmology 133(5): 601-606, 2002

Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia. Cornea 21(7): 715-717, 2002

Total regression of extensive conjunctival intraepithelial neoplasia with superficial corneal invasion treated with topical mitomycin C 0.02%. Bmj Case Reports 2009:, 2009

The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia. Seminars in Ophthalmology 29(4): 192-195, 2014

Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea 18(1): 59-62, 1999

Superficial keratectomy and topical mitomycin C as therapy for a corneal squamous cell carcinoma in a dog. Journal of Small Animal Practice 49(4): 208-210, 2008

Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%. Archivos de la Sociedad Espanola de Oftalmologia 79(8): 375-378, 2004